GREENHAVEN ASSOCIATES INC
โขCIK: 846222โขFiling: Q4 2025
Greenhaven Associates Inc., managed by the seasoned investor team known for a concentrated, value-oriented approach, currently holds $6.2 billion in assets, with a notable 20% allocation to GM. Recently, the fund has shifted focus by exiting Goldman Sachs, cutting positions in Textron and Truist Financial, and adding significant stakes in Vertex Pharmaceuticals and Bristol Myers Squibb, reflecting a strategic pivot towards healthcare and industrials.
Total AUM
$6.2B
QoQ Performance
-6.2%
Positions
30
Top 10 Concentration
86.7%
Latest Filing
Q4 2025
Top Holdings Allocation
GM
LEN
TOL
PHM
DHI
OSK
GM20.0%
LEN16.8%
TOL12.3%
PHM10.5%
DHI8.1%
OSK5.1%
AVTR3.8%
ARW3.4%
๐ Biggest Buys
๐ Biggest Sells
Sector Breakdown
Other80.2%
Consumer16.8%
Energy2.9%
Financial0.0%
Materials0.0%
Industrial0.0%
๐ช Exited Positionssold since Q3 2025
Changes from Q3 2025
NEW4 new positions
โ7 increased
โ13 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023